Clinical virologist
Toulouse University Hospital
Dr. Camille Vellas is a clinical virologist and postdoctoral researcher at Toulouse University Hospital and the Toulouse Institute for Infectious and Inflammatory Diseases (INFINITY, INSERM UMR1291 – CNRS UMR5051 – Université de Toulouse) in France. She obtained her PharmD and PhD in Immunology under the supervision of Professor Pierre Delobel in 2023. Her doctoral research, entitled “Molecular Forms of HIV-1 Persistence and Target Cells in the Intestinal Compartment,” explored the mechanisms of viral persistence in the gut mucosa of people living with HIV (PLWH) under ART.
Her current research focuses on the blood and intestinal HIV reservoirs, mucosal immune activation, and host–microbiota interactions. She also studies the evolution of respiratory viruses such as SARS-CoV-2, RSV, and Influenza, and recently implementing long-read sequencing protocols (HIV, PacBio) to analyze genome diversity.
Dr. Vellas aims to better understand the mechanisms underlying HIV persistence during antiretroviral therapy and to identify new immunological and metabolic pathways involved in viral control. She is particularly interested in translational approaches bridging clinical virology and mucosal immunology.